COVID-19 and the Physio4FMD trial: Impact, mitigating strategies and analysis plans

Authors: Marston, Louise;

Le novere, Marie;

Ricciardi, Federico;

Nazareth, Irwin;

Carson, Alan;

Edwards, Mark;

Goldstein, Laura H.;

Marsden, Jonathan;

Noble, Hayley;

Reuber, Markus;

Stone, Jon;

Hunter, Rachael M.;

Nielsen, Glenn

Source: Contemporary clinical trials communications

Full text

: https://doi.org/10.1016/j.conctc.2023.101124

Abstract

Rights

Cite as

Marston, L., Le novere, M., Ricciardi, F., Nazareth, I., Carson, A., Edwards, M., Goldstein, L., Marsden, J., Noble, H., Reuber, M., Stone, J., Hunter, R. & Nielsen, G. 2023, 'COVID-19 and the Physio4FMD trial: Impact, mitigating strategies and analysis plans', Contemporary clinical trials communications, 33, article no: 101124. https://doi.org/10.1016/j.conctc.2023.101124

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.1016/j.conctc.2023.101124

Repository URI: https://www.research.ed.ac.uk/en/publications/c0a51d5c-1dd1-402e-b5c1-ba44cfaf627a